These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
559 related articles for article (PubMed ID: 8163651)
21. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. Onoe Y; Miyaura C; Kaminakayashiki T; Nagai Y; Noguchi K; Chen QR; Seo H; Ohta H; Nozawa S; Kudo I; Suda T J Immunol; 1996 Jan; 156(2):758-64. PubMed ID: 8543830 [TBL] [Abstract][Full Text] [Related]
22. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors. Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859 [TBL] [Abstract][Full Text] [Related]
23. Nitric oxide acts in conjunction with proinflammatory cytokines to promote cell death in osteoblasts. Damoulis PD; Hauschka PV J Bone Miner Res; 1997 Mar; 12(3):412-22. PubMed ID: 9076584 [TBL] [Abstract][Full Text] [Related]
24. Interleukin 1 beta markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Kitade H; Sakitani K; Inoue K; Masu Y; Kawada N; Hiramatsu Y; Kamiyama Y; Okumura T; Ito S Hepatology; 1996 Apr; 23(4):797-802. PubMed ID: 8666334 [TBL] [Abstract][Full Text] [Related]
25. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. Ding AH; Nathan CF; Stuehr DJ J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757 [TBL] [Abstract][Full Text] [Related]
26. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis. Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508 [TBL] [Abstract][Full Text] [Related]
27. NO-dependent and NO-independent IL-1 production by a human colonic epithelial cell line under inflammatory stress. Vallette G; Jarry A; Lemarre P; Branka JE; Laboisse CL Br J Pharmacol; 1997 May; 121(2):187-92. PubMed ID: 9154326 [TBL] [Abstract][Full Text] [Related]
28. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Deakin AM; Payne AN; Whittle BJ; Moncada S Cytokine; 1995 Jul; 7(5):408-16. PubMed ID: 7578978 [TBL] [Abstract][Full Text] [Related]
29. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Gazzinelli RT; Oswald IP; Hieny S; James SL; Sher A Eur J Immunol; 1992 Oct; 22(10):2501-6. PubMed ID: 1396957 [TBL] [Abstract][Full Text] [Related]
30. Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes. Adamson GM; Billings RE Toxicol Appl Pharmacol; 1993 Mar; 119(1):100-7. PubMed ID: 7682342 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-17: A new bone acting cytokine in vitro. Van bezooijen RL; Farih-Sips HC; Papapoulos SE; Löwik CW J Bone Miner Res; 1999 Sep; 14(9):1513-21. PubMed ID: 10469279 [TBL] [Abstract][Full Text] [Related]
32. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. Maciejewski JP; Selleri C; Sato T; Cho HJ; Keefer LK; Nathan CF; Young NS J Clin Invest; 1995 Aug; 96(2):1085-92. PubMed ID: 7543491 [TBL] [Abstract][Full Text] [Related]
33. Induction of nitric oxide synthase in human mesangial cells. Nicolson AG; Haites NE; McKay NG; Wilson HM; MacLeod AM; Benjamin N Biochem Biophys Res Commun; 1993 Jun; 193(3):1269-74. PubMed ID: 7686752 [TBL] [Abstract][Full Text] [Related]
34. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Lee SK; Huang H; Lee SW; Kim KH; Kim KK; Kim HM; Lee ZH; Kim HH Exp Cell Res; 2004 Aug; 298(2):359-68. PubMed ID: 15265685 [TBL] [Abstract][Full Text] [Related]
36. Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release. Griffon B; Cillard J; Chevanne M; Morel I; Cillard P; Sergent O Hepatology; 1998 Nov; 28(5):1300-8. PubMed ID: 9794915 [TBL] [Abstract][Full Text] [Related]
37. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. Kim CK; Rivier C J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649 [TBL] [Abstract][Full Text] [Related]
38. Expression and functional role of nitric oxide synthase in osteoblast-like cells. Riancho JA; Salas E; Zarrabeitia MT; Olmos JM; Amado JA; Fernández-Luna JL; González-Macías J J Bone Miner Res; 1995 Mar; 10(3):439-46. PubMed ID: 7540349 [TBL] [Abstract][Full Text] [Related]
39. Nitric oxide promotes the progression of periapical lesion via inducing macrophage and osteoblast apoptosis. Lin SK; Kok SH; Lin LD; Wang CC; Kuo MY; Lin CT; Hsiao M; Hong CY Oral Microbiol Immunol; 2007 Feb; 22(1):24-9. PubMed ID: 17241167 [TBL] [Abstract][Full Text] [Related]
40. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha. Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]